Serveur d'exploration Tocilizumab - Analysis (France)

Index « Auteurs » - entrée « Marie Godfrin-Valnet »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Marie Fournier < Marie Godfrin-Valnet < Marie Gosset  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000375 (2015) Clémentine Fortunet [France] ; Yves-Marie Pers [France] ; Joseph Lambert [France] ; Marie Godfrin-Valnet [France] ; Elodie Constant [France] ; Hervé Devilliers [France] ; Philippe Gaudin [France] ; Christian Jorgensen [France] ; Béatrice Pallot Prades [France] ; Daniel Wendling [France] ; Jean Francis Maillefert [France]Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice.
000383 (2015) Yves-Marie Pers [France] ; Marie Godfrin-Valnet ; Joseph Lambert ; Clémentine Fortunet ; Elodie Constant ; Thibault Mura ; Béatrice Pallot-Prades ; Christian Jorgensen ; Jean-Francis Maillefert ; Hubert Marotte ; Daniel Wendling ; Philippe GaudinResponse to tocilizumab in rheumatoid arthritis is not influenced by the body mass index of the patient.
000404 (2015) Yves-Marie Pers [France] ; Roxane Schaub [France] ; Elodie Constant [France] ; Joseph Lambert [France] ; Marie Godfrin-Valnet [France] ; Clémentine Fortunet [France] ; Waafa Bourichi [France] ; Béatrice Pallot Prades [France] ; Daniel Wendling [France] ; Philippe Gaudin [France] ; Christian Jorgensen [France] ; Jean-Francis Maillefert [France] ; Hubert Marotte [France]Efficacy and safety of tocilizumab in elderly patients with rheumatoid arthritis.
000444 (2014) Yves-Marie Pers [France] ; Clémentine Fortunet ; Elodie Constant ; Joseph Lambert ; Marie Godfrin-Valnet ; Audrey De Jong ; Grégoire Mercier ; Béatrice Pallot Prades ; Daniel Wendling ; Philippe Gaudin ; Christian Jorgensen ; Hubert Marotte ; Jean-Francis MaillefertPredictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice.
000450 (2014) Claire Vidon [France] ; Marie Bossert [France] ; Anne Lohse-Walliser [France] ; Marie Godfrin-Valnet [France] ; Jean-Charles Balblanc [France] ; Daniel Wendling [France]Hair-cycle changes in two patients taking tocilizumab.
000470 (2014) Claire Vidon [France] ; Marie Bossert [France] ; Anne Lohse-Walliser [France] ; Marie Godfrin-Valnet [France] ; Jean-Charles Balblanc [France] ; Daniel Wendling [France]Trouble du cycle capillaire sous tocilizumab
000500 (2013) Daniel Wendling [France] ; Claire Vidon ; Marie Godfrin-Valnet ; Gilles Rival ; Xavier Guillot ; Clément PratiExacerbation of combined pulmonary fibrosis and emphysema syndrome during tocilizumab therapy for rheumatoid arthritis.
000607 (2013) Claire Vidon [France] ; Marie Godfrin-Valnet [France] ; Gilles Rival [France] ; Xavier Guillot [France] ; Clément Prati [France]Aggravation d'un syndrome emphysème des sommets - fibrose des bases pulmonaire lors d'un traitement d'une polyarthrite rhumatoïde par tocilizumab

List of associated KwdEn.i

Nombre de
documents
Descripteur
6Arthritis, Rheumatoid (drug therapy)
6Humans
6Male
6Middle Aged
5Antibodies, Monoclonal, Humanized (therapeutic use)
5Female
4Antirheumatic Agents (therapeutic use)
4Retrospective Studies
4Treatment Outcome
3Aged
2Adult
2Immunomodulator
2Immunosuppressive agent
2Rheumatology
2Tocilizumab
1Adrenal Cortex Hormones (therapeutic use)
1Aggravation
1Alopecia
1Antibodies, Monoclonal, Humanized (adverse effects)
1Antibodies, Monoclonal, Humanized (pharmacology)
1Antirheumatic Agents (adverse effects)
1Antirheumatic Agents (pharmacology)
1Arthritis, Juvenile (drug therapy)
1Arthritis, Rheumatoid (complications)
1Arthritis, Rheumatoid (diagnosis)
1Arthritis, Rheumatoid (metabolism)
1Arthritis, Rheumatoid (physiopathology)
1Body Mass Index
1Chronic
1Drug Therapy, Combination
1Emphysema
1Follow-Up Studies
1Glucocorticoids (therapeutic use)
1Hair
1Hair (drug effects)
1Hair (physiology)
1Interleukin 6
1Interstitial pneumonitis
1Prednisone (therapeutic use)
1Prognosis
1Pulmonary Emphysema (chemically induced)
1Pulmonary Emphysema (etiology)
1Pulmonary Fibrosis (chemically induced)
1Pulmonary Fibrosis (etiology)
1Pulmonary fibrosis
1ROC Curve
1Remission Induction
1Rheumatoid arthritis
1Severity of Illness Index
1Treatment
1Tumor Necrosis Factor-alpha (antagonists & inhibitors)
1Tumor Necrosis Factor-alpha (metabolism)
1biologics
1corticosteroids
1diseases
1eular recommendations
1factor-alpha inhibitors
1management
1rheumatoid arthritis
1risk
1systemic glucocorticoid therapy
1tocilizumab
1treatment

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Marie Godfrin-Valnet" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Marie Godfrin-Valnet" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Marie Godfrin-Valnet
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021